CytomX Therapeutics Inc (NASDAQ:CTMX)

5.27
Delayed Data
As of Sep 24
 -0.17 / -3.13%
Today’s Change
4.28
Today|||52-Week Range
10.05
-19.54%
Year-to-Date
No recent news for CytomX Therapeutics Inc.

Today’s Trading

Previous close5.44
Today’s open5.41
Day’s range5.23 - 5.45
Volume22,924
Average volume (3 months)705,442
Market cap$340.8M
Data as of 4:17pm ET, 09/24/2021

Growth & Valuation

Earnings growth (last year)+68.40%
Earnings growth (this year)-61.48%
Earnings growth (next 5 years)+0.62%
Revenue growth (last year)+74.58%
P/E ratioNM
Price/Sales3.01
Price/Book5.07

Competitors

 Today’s
change
Today’s
% change
OCXOncoCyte Corp-0.31-7.75%
EYPTEyePoint Pharmaceuti...+0.44+3.93%
ATNXAthenex Inc-0.20-5.85%
TCRRTCR2 Therapeutics In...-0.30-3.34%
Data as of 4:14pm ET, 09/24/2021

Financials

Next reporting dateNovember 9, 2021
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$100.4M
Annual profit (last year)-$32.9M
Net profit margin-32.77%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts